NEXT VENTŪRES Newsletter

Home
Archive
About
Investing in Vital Bio: A New Frontier in Diagnostics
Reimagining lab testing to enable radically accessible care.
 • 
NEXT VENTŪRES
New
Top
Community
VBC Enablement: Paving The Way for Value
Examining the continued rise of VBC enablement and its ability to help transition providers to value.
 • 
NEXT VENTŪRES
 and 
Jordan Pascasio
A New Year of Whole-person Health
Reflecting on the market and our thesis, while anticipating thematic developments in the year to come.
 • 
NEXT VENTŪRES
Our 17th Investment: Juno Medical
The modern doctor's office designed for the 99%.
 • 
NEXT VENTŪRES
Our 16th Investment: Genopets
Democratizing active lifestyles through immersive gameplay.
 • 
NEXT VENTŪRES
Introducing Our Newest Advisor, Healthcare Strategist R.J. Briscione
Investing in founders and companies defining whole person health has been a priority for us in 2022 as we look to democratize access to a healthier…
 • 
NEXT VENTŪRES
Our 15th Investment: Trial Library
Improving Health Equity Through Clinical Trials.
 • 
NEXT VENTŪRES
Opportunity Within Clinical Trials
Examining how innovation within clinical trails can address the awareness, access and patient mistrust issues that limit the industry's true potential.
 • 
NEXT VENTŪRES
NEXT VENTŪRES Newsletter
NEXT VENTŪRES Newsletter
Exploring innovation across whole-person health.

NEXT VENTŪRES Newsletter

AboutArchiveSitemap
© 2023 NEXT VENTŪRES
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing